Expansion of Intracoronary Stents by Low Pressure Oversizing Versus High Pressure Inflation: A Randomised Intracoronary Ultrasound Controlled Study
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2018
Price : $35 *
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 14 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Nov 2016.
- 14 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 20 Nov 2015 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.